Window for endovascular stroke treatment may be extended by new study

The window for stroke therapy refers to the time limit after the onset of symptoms when treatment can still be made available. A new study, presented at the European Stroke Organization conference in Prague last month, may extend this window to 24 hours for carefully selected patients.┬áThe trial, known as DAWN, selected patients for treatment … Read more…

Cost of Stroke Treatment Rises

The only available drug for the treatment of the most common type of stroke is the clot buster known as tPA. This treatment was first approved by FDA 20 years ago. The cost of tPA jumped by 111% between 2005 and 2014, but reimbursement rose by only 8%, reported Dawn Kleindorfer, MD, University of Cincinnati, … Read more…

Progress for Interventional Stroke Therapy

In 1995 the clot dissolving drug tPA was first demonstrated to be effective in the treatment of the most common type of stroke, those caused by blood clots plugging arteries in the brain. Since that time, no newer therapy has been proven to improve the outcome of stroke patients compared to tPA. But tPA treatment … Read more…

New Guidelines for Treatment of Obstructive Sleep Apnea

Sleep apnea is a condition which increases the risk of high blood pressure, heart attack, stroke, heart failure, and diabetes and increases the chance of car accidents or other accidents. Sleep apnea is a leading cause of excessive daytime sleepiness. The most common type is known as obstructive sleep apnea. Symptoms may include snoring and … Read more…